Structure

Physi-Chem Properties

Molecular Weight:  578.16
Volume:  534.737
LogP:  1.133
LogD:  0.296
LogS:  -3.357
# Rotatable Bonds:  5
TPSA:  232.9
# H-Bond Aceptor:  14
# H-Bond Donor:  8
# Rings:  5
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.167
Synthetic Accessibility Score:  4.683
Fsp3:  0.481
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.452
MDCK Permeability:  1.8387918316875584e-05
Pgp-inhibitor:  0.828
Pgp-substrate:  0.966
Human Intestinal Absorption (HIA):  0.837
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.093
Plasma Protein Binding (PPB):  91.53166961669922%
Volume Distribution (VD):  0.76
Pgp-substrate:  4.064772129058838%

ADMET: Metabolism

CYP1A2-inhibitor:  0.039
CYP1A2-substrate:  0.048
CYP2C19-inhibitor:  0.02
CYP2C19-substrate:  0.057
CYP2C9-inhibitor:  0.006
CYP2C9-substrate:  0.062
CYP2D6-inhibitor:  0.034
CYP2D6-substrate:  0.121
CYP3A4-inhibitor:  0.047
CYP3A4-substrate:  0.049

ADMET: Excretion

Clearance (CL):  2.099
Half-life (T1/2):  0.421

ADMET: Toxicity

hERG Blockers:  0.253
Human Hepatotoxicity (H-HT):  0.082
Drug-inuced Liver Injury (DILI):  0.928
AMES Toxicity:  0.871
Rat Oral Acute Toxicity:  0.018
Maximum Recommended Daily Dose:  0.004
Skin Sensitization:  0.054
Carcinogencity:  0.563
Eye Corrosion:  0.003
Eye Irritation:  0.193
Respiratory Toxicity:  0.009

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475246

Natural Product ID:  NPC475246
Common Name*:   2-Methyl-1,3,6-Trihydroxyl-9,10-Anthraquinone 3-O-Alpha-Rhamnosyl(1->2)Glucoside
IUPAC Name:   3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,6-dihydroxy-2-methylanthracene-9,10-dione
Synonyms:  
Standard InCHIKey:  UMBHTGLJTANWCB-YORKFUMESA-N
Standard InCHI:  InChI=1S/C27H30O14/c1-8-14(6-13-16(17(8)30)20(33)11-4-3-10(29)5-12(11)19(13)32)39-27-25(23(36)21(34)15(7-28)40-27)41-26-24(37)22(35)18(31)9(2)38-26/h3-6,9,15,18,21-31,34-37H,7H2,1-2H3/t9-,15-,18-,21-,22+,23+,24+,25-,26+,27-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2cc3C(=O)c4cc(O)ccc4C(=O)c3c(c2C)O)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1O[C@H](C)[C@H]([C@@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL501915
PubChem CID:   44575695
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000018] Anthracenes
        • [CHEMONTID:0000151] Anthraquinones
          • [CHEMONTID:0001598] Hydroxyanthraquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28159 Rubia akane Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[8176404]
NPO28159 Rubia akane Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO28159 Rubia akane Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20967 CELL-LINE Platelet n.a. Activity = 87.0 % PMID[522437]
NPT20967 CELL-LINE Platelet n.a. Activity = 83.4 % PMID[522437]
NPT20967 CELL-LINE Platelet n.a. Activity = 84.0 % PMID[522437]
NPT20967 CELL-LINE Platelet n.a. Activity = 89.4 % PMID[522437]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475246 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9939 High Similarity NPC3718
0.9878 High Similarity NPC46958
0.9819 High Similarity NPC477860
0.9819 High Similarity NPC475161
0.9816 High Similarity NPC30432
0.9816 High Similarity NPC111536
0.9816 High Similarity NPC271385
0.9816 High Similarity NPC76128
0.9816 High Similarity NPC5029
0.9759 High Similarity NPC153578
0.9759 High Similarity NPC114257
0.9759 High Similarity NPC277710
0.9759 High Similarity NPC299149
0.9697 High Similarity NPC68381
0.9693 High Similarity NPC222455
0.9645 High Similarity NPC87583
0.9639 High Similarity NPC475233
0.9524 High Similarity NPC212290
0.9518 High Similarity NPC85368
0.9518 High Similarity NPC98776
0.9518 High Similarity NPC213052
0.9515 High Similarity NPC298778
0.9474 High Similarity NPC105591
0.9461 High Similarity NPC146803
0.9455 High Similarity NPC259905
0.9451 High Similarity NPC178851
0.9401 High Similarity NPC199357
0.9401 High Similarity NPC203751
0.9401 High Similarity NPC472054
0.9387 High Similarity NPC101116
0.9387 High Similarity NPC278329
0.9387 High Similarity NPC146837
0.9387 High Similarity NPC212099
0.9353 High Similarity NPC315221
0.9345 High Similarity NPC63105
0.9345 High Similarity NPC474345
0.9298 High Similarity NPC313452
0.9294 High Similarity NPC245059
0.9294 High Similarity NPC84494
0.929 High Similarity NPC102053
0.929 High Similarity NPC289876
0.9277 High Similarity NPC63470
0.9273 High Similarity NPC478022
0.9273 High Similarity NPC178281
0.9273 High Similarity NPC478020
0.9268 High Similarity NPC216752
0.9268 High Similarity NPC44947
0.9264 High Similarity NPC472320
0.924 High Similarity NPC164047
0.924 High Similarity NPC470453
0.924 High Similarity NPC470448
0.924 High Similarity NPC470452
0.9231 High Similarity NPC470454
0.9231 High Similarity NPC199533
0.9212 High Similarity NPC257566
0.9212 High Similarity NPC124155
0.9207 High Similarity NPC47923
0.9207 High Similarity NPC303913
0.9191 High Similarity NPC229817
0.9191 High Similarity NPC475352
0.9191 High Similarity NPC473686
0.9191 High Similarity NPC475220
0.9191 High Similarity NPC221140
0.9186 High Similarity NPC293227
0.9186 High Similarity NPC473631
0.9186 High Similarity NPC475662
0.9186 High Similarity NPC473717
0.9181 High Similarity NPC58538
0.9167 High Similarity NPC150767
0.9167 High Similarity NPC78734
0.9152 High Similarity NPC259834
0.9152 High Similarity NPC190450
0.9146 High Similarity NPC271479
0.9141 High Similarity NPC23817
0.9128 High Similarity NPC197357
0.9128 High Similarity NPC85316
0.9112 High Similarity NPC256760
0.9107 High Similarity NPC473202
0.9107 High Similarity NPC246274
0.9107 High Similarity NPC229687
0.9102 High Similarity NPC178173
0.9102 High Similarity NPC70441
0.9091 High Similarity NPC264302
0.9085 High Similarity NPC73511
0.9085 High Similarity NPC308265
0.908 High Similarity NPC170475
0.908 High Similarity NPC206378
0.908 High Similarity NPC241847
0.9059 High Similarity NPC208668
0.9059 High Similarity NPC154986
0.9059 High Similarity NPC168789
0.9053 High Similarity NPC478021
0.9053 High Similarity NPC241874
0.9053 High Similarity NPC76047
0.9053 High Similarity NPC218488
0.9053 High Similarity NPC51326
0.9053 High Similarity NPC231194
0.9053 High Similarity NPC44558
0.9048 High Similarity NPC249977
0.9048 High Similarity NPC45400
0.9048 High Similarity NPC477502
0.9042 High Similarity NPC99216
0.904 High Similarity NPC470199
0.904 High Similarity NPC314459
0.9036 High Similarity NPC131745
0.9036 High Similarity NPC472876
0.9034 High Similarity NPC314672
0.903 High Similarity NPC142860
0.903 High Similarity NPC97285
0.903 High Similarity NPC271270
0.903 High Similarity NPC328093
0.903 High Similarity NPC246469
0.9024 High Similarity NPC473512
0.9024 High Similarity NPC129827
0.9024 High Similarity NPC156457
0.9024 High Similarity NPC161749
0.9024 High Similarity NPC197896
0.9024 High Similarity NPC44931
0.9024 High Similarity NPC313163
0.9024 High Similarity NPC258035
0.9024 High Similarity NPC65003
0.9023 High Similarity NPC224557
0.9023 High Similarity NPC292706
0.9018 High Similarity NPC97052
0.9018 High Similarity NPC99233
0.9018 High Similarity NPC39351
0.9018 High Similarity NPC26195
0.9018 High Similarity NPC169248
0.9018 High Similarity NPC72649
0.9012 High Similarity NPC472387
0.9006 High Similarity NPC294629
0.9006 High Similarity NPC223735
0.9006 High Similarity NPC186800
0.9006 High Similarity NPC108202
0.9006 High Similarity NPC307754
0.9006 High Similarity NPC470667
0.9 High Similarity NPC294501
0.9 High Similarity NPC267254
0.9 High Similarity NPC315619
0.9 High Similarity NPC67134
0.9 High Similarity NPC47140
0.9 High Similarity NPC301683
0.8994 High Similarity NPC472381
0.8994 High Similarity NPC472383
0.8994 High Similarity NPC470206
0.8994 High Similarity NPC470207
0.8994 High Similarity NPC61791
0.8994 High Similarity NPC5319
0.8994 High Similarity NPC293629
0.8994 High Similarity NPC43587
0.8988 High Similarity NPC236934
0.8988 High Similarity NPC115674
0.8988 High Similarity NPC210073
0.8988 High Similarity NPC5778
0.8982 High Similarity NPC179198
0.8982 High Similarity NPC29830
0.8982 High Similarity NPC66087
0.8982 High Similarity NPC183672
0.8982 High Similarity NPC278419
0.8977 High Similarity NPC205721
0.897 High Similarity NPC22062
0.897 High Similarity NPC138811
0.897 High Similarity NPC473634
0.897 High Similarity NPC53139
0.8966 High Similarity NPC132111
0.8963 High Similarity NPC261866
0.8963 High Similarity NPC78492
0.8963 High Similarity NPC45165
0.8963 High Similarity NPC208152
0.8957 High Similarity NPC106625
0.8953 High Similarity NPC324220
0.8953 High Similarity NPC312630
0.8947 High Similarity NPC236191
0.8947 High Similarity NPC239549
0.8947 High Similarity NPC51774
0.8947 High Similarity NPC25724
0.8941 High Similarity NPC474434
0.8941 High Similarity NPC199079
0.8941 High Similarity NPC177731
0.8941 High Similarity NPC34287
0.8941 High Similarity NPC471416
0.8941 High Similarity NPC105095
0.8941 High Similarity NPC79056
0.8941 High Similarity NPC210808
0.8941 High Similarity NPC105511
0.8941 High Similarity NPC21190
0.8941 High Similarity NPC183357
0.8941 High Similarity NPC22195
0.8941 High Similarity NPC44328
0.8939 High Similarity NPC470194
0.8939 High Similarity NPC470193
0.8939 High Similarity NPC470198
0.8939 High Similarity NPC470195
0.8939 High Similarity NPC470196
0.8939 High Similarity NPC470200
0.8939 High Similarity NPC470197
0.8939 High Similarity NPC282474
0.8939 High Similarity NPC316274
0.8935 High Similarity NPC225419
0.8935 High Similarity NPC93099

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475246 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9024 High Similarity NPD4381 Clinical (unspecified phase)
0.8994 High Similarity NPD7804 Clinical (unspecified phase)
0.8941 High Similarity NPD7074 Phase 3
0.892 High Similarity NPD7879 Clinical (unspecified phase)
0.8882 High Similarity NPD7054 Approved
0.8862 High Similarity NPD6959 Discontinued
0.8844 High Similarity NPD8312 Approved
0.8844 High Similarity NPD8313 Approved
0.8837 High Similarity NPD6559 Discontinued
0.883 High Similarity NPD7472 Approved
0.8779 High Similarity NPD6797 Phase 2
0.8728 High Similarity NPD7251 Discontinued
0.8713 High Similarity NPD3818 Discontinued
0.8678 High Similarity NPD7808 Phase 3
0.8659 High Similarity NPD4380 Phase 2
0.8596 High Similarity NPD6166 Phase 2
0.8596 High Similarity NPD6168 Clinical (unspecified phase)
0.8596 High Similarity NPD6167 Clinical (unspecified phase)
0.8579 High Similarity NPD6780 Approved
0.8579 High Similarity NPD6779 Approved
0.8579 High Similarity NPD6777 Approved
0.8579 High Similarity NPD6778 Approved
0.8579 High Similarity NPD6781 Approved
0.8579 High Similarity NPD6776 Approved
0.8579 High Similarity NPD6782 Approved
0.8511 High Similarity NPD8151 Discontinued
0.8503 High Similarity NPD2393 Clinical (unspecified phase)
0.8503 High Similarity NPD7819 Suspended
0.848 Intermediate Similarity NPD6232 Discontinued
0.8466 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD7075 Discontinued
0.8448 Intermediate Similarity NPD5844 Phase 1
0.8441 Intermediate Similarity NPD7698 Approved
0.8441 Intermediate Similarity NPD7697 Approved
0.8441 Intermediate Similarity NPD7435 Discontinued
0.8441 Intermediate Similarity NPD7696 Phase 3
0.8439 Intermediate Similarity NPD7473 Discontinued
0.836 Intermediate Similarity NPD7701 Phase 2
0.8343 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD1934 Approved
0.8306 Intermediate Similarity NPD6534 Approved
0.8306 Intermediate Similarity NPD6535 Approved
0.8298 Intermediate Similarity NPD7871 Phase 2
0.8298 Intermediate Similarity NPD7870 Phase 2
0.8294 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8286 Intermediate Similarity NPD3751 Discontinued
0.8284 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD7411 Suspended
0.827 Intermediate Similarity NPD7700 Phase 2
0.827 Intermediate Similarity NPD7699 Phase 2
0.8256 Intermediate Similarity NPD5494 Approved
0.8229 Intermediate Similarity NPD7783 Phase 2
0.8229 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD6801 Discontinued
0.8191 Intermediate Similarity NPD6823 Phase 2
0.8187 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD7228 Approved
0.8177 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.8177 Intermediate Similarity NPD7874 Approved
0.8171 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8155 Intermediate Similarity NPD3226 Approved
0.8146 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8135 Intermediate Similarity NPD7801 Approved
0.8133 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8105 Intermediate Similarity NPD8320 Phase 1
0.8105 Intermediate Similarity NPD8319 Approved
0.8098 Intermediate Similarity NPD1549 Phase 2
0.807 Intermediate Similarity NPD2801 Approved
0.8057 Intermediate Similarity NPD3787 Discontinued
0.8054 Intermediate Similarity NPD6213 Phase 3
0.8054 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.8054 Intermediate Similarity NPD6212 Phase 3
0.8037 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8037 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8024 Intermediate Similarity NPD2532 Approved
0.8024 Intermediate Similarity NPD2534 Approved
0.8024 Intermediate Similarity NPD2533 Approved
0.8023 Intermediate Similarity NPD5402 Approved
0.8 Intermediate Similarity NPD6599 Discontinued
0.7977 Intermediate Similarity NPD3882 Suspended
0.7965 Intermediate Similarity NPD1465 Phase 2
0.7965 Intermediate Similarity NPD8455 Phase 2
0.7931 Intermediate Similarity NPD3749 Approved
0.7919 Intermediate Similarity NPD3817 Phase 2
0.7914 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD37 Approved
0.7886 Intermediate Similarity NPD6234 Discontinued
0.788 Intermediate Similarity NPD8150 Discontinued
0.7874 Intermediate Similarity NPD4967 Phase 2
0.7874 Intermediate Similarity NPD4966 Approved
0.7874 Intermediate Similarity NPD4965 Approved
0.7874 Intermediate Similarity NPD7768 Phase 2
0.7866 Intermediate Similarity NPD2796 Approved
0.7857 Intermediate Similarity NPD1511 Approved
0.7857 Intermediate Similarity NPD6799 Approved
0.7857 Intermediate Similarity NPD7390 Discontinued
0.7836 Intermediate Similarity NPD7458 Discontinued
0.7824 Intermediate Similarity NPD5403 Approved
0.7818 Intermediate Similarity NPD2346 Discontinued
0.7805 Intermediate Similarity NPD1510 Phase 2
0.7802 Intermediate Similarity NPD7240 Approved
0.7797 Intermediate Similarity NPD7199 Phase 2
0.7791 Intermediate Similarity NPD1607 Approved
0.7784 Intermediate Similarity NPD3750 Approved
0.7784 Intermediate Similarity NPD4628 Phase 3
0.7772 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD1512 Approved
0.7744 Intermediate Similarity NPD7584 Approved
0.7733 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD5401 Approved
0.7692 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD1240 Approved
0.7665 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7611 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7585 Intermediate Similarity NPD8059 Phase 3
0.7585 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD5711 Approved
0.7556 Intermediate Similarity NPD5710 Approved
0.7554 Intermediate Similarity NPD5953 Discontinued
0.7545 Intermediate Similarity NPD1551 Phase 2
0.7545 Intermediate Similarity NPD2935 Discontinued
0.7515 Intermediate Similarity NPD2800 Approved
0.7515 Intermediate Similarity NPD6674 Discontinued
0.7514 Intermediate Similarity NPD7685 Pre-registration
0.75 Intermediate Similarity NPD8434 Phase 2
0.75 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD3748 Approved
0.7471 Intermediate Similarity NPD1653 Approved
0.7461 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD6100 Approved
0.744 Intermediate Similarity NPD6099 Approved
0.7436 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7418 Intermediate Similarity NPD3926 Phase 2
0.7414 Intermediate Similarity NPD920 Approved
0.7385 Intermediate Similarity NPD8285 Discontinued
0.7385 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD2799 Discontinued
0.7368 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD7286 Phase 2
0.735 Intermediate Similarity NPD7585 Approved
0.7337 Intermediate Similarity NPD5405 Approved
0.7337 Intermediate Similarity NPD5406 Approved
0.7337 Intermediate Similarity NPD5408 Approved
0.7337 Intermediate Similarity NPD5404 Approved
0.7333 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7680 Approved
0.7308 Intermediate Similarity NPD1247 Approved
0.73 Intermediate Similarity NPD7583 Approved
0.7299 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD2344 Approved
0.7294 Intermediate Similarity NPD7266 Discontinued
0.7293 Intermediate Similarity NPD919 Approved
0.7287 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4625 Phase 3
0.7268 Intermediate Similarity NPD4360 Phase 2
0.7268 Intermediate Similarity NPD7229 Phase 3
0.7268 Intermediate Similarity NPD4363 Phase 3
0.7267 Intermediate Similarity NPD7003 Approved
0.7257 Intermediate Similarity NPD6273 Approved
0.7246 Intermediate Similarity NPD943 Approved
0.7246 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD1613 Approved
0.7241 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD1470 Approved
0.7229 Intermediate Similarity NPD2313 Discontinued
0.7229 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.722 Intermediate Similarity NPD7930 Approved
0.7212 Intermediate Similarity NPD4908 Phase 1
0.7209 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD1243 Approved
0.7204 Intermediate Similarity NPD7177 Discontinued
0.7184 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD6651 Approved
0.7126 Intermediate Similarity NPD6190 Approved
0.7126 Intermediate Similarity NPD2309 Approved
0.7118 Intermediate Similarity NPD7097 Phase 1
0.7109 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD1933 Approved
0.7101 Intermediate Similarity NPD230 Phase 1
0.7095 Intermediate Similarity NPD8366 Approved
0.7091 Intermediate Similarity NPD2798 Approved
0.7076 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD5761 Phase 2
0.7072 Intermediate Similarity NPD5760 Phase 2
0.7062 Intermediate Similarity NPD4287 Approved
0.7056 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD4060 Phase 1
0.7027 Intermediate Similarity NPD8127 Discontinued
0.7021 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7017 Intermediate Similarity NPD6844 Discontinued
0.7006 Intermediate Similarity NPD6832 Phase 2
0.7006 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD5124 Phase 1
0.7 Intermediate Similarity NPD447 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data